CLIENT NEWS
- Marinomed Biotech AG reports increase in revenues for the first 9 months 2022 and significant business development progress21 November 2022
- ONWARD Awarded European Innovation Council Grant to Further Develop Brain-Computer Interface Technology; Company also Wins First Place in 2022 Brain-Computer Interface Awards21 November 2022
- After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board21 November 2022
- Element Materials Unveils One of the First and Largest Air Treatment Testing Facilities Designed to Support Indoor Space Public Health Air Quality16 November 2022
- Lindis Blood Care Establishes Scientific Advisory Board of Leading Industry Experts16 November 2022
- Rentschler Biopharma appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board16 November 2022
- ABIVAX RELEASES THE RESULTS OF ITS NOVEMBER 9, 2022 AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING15 November 2022
- Destiny Pharma: XF-73 Dermal infection project advances into clinically enabling safety study with US Government’s NIAID15 November 2022
- Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert15 November 2022
- LINDIS Biotech Presented Encouraging Data from High Risk-Non-Muscle-Invasive Bladder Cancer Patients Treated with Trifunctional Antibody CATUMAXOMAB at EMUC2214 November 2022